Applied DNA Sciences Inc (APDN)

[Foose]

Looks like $4 was the floor and now more news.

Applied DNA Ships LinearDNA™ to Another Development Customer

TONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables diagnostics, pre-clinical nucleic acid-based therapeutic drug candidates, supply chain security, anti-counterfeiting and anti-theft technology, announced today that it has shipped two CAR T amplicons proprietary to the biologics subsidiary of a U.S.-based, global biopharmaceutical company. The customer is one of nearly two dozen development customers in various stages of evaluating the use of linear DNA manufactured by the Company.

“We see a steady flow of interest for our LinearDNA™ manufacturing platform from customers with gene and redirected-cell therapies. Securing development customers is the first step in our LinearDNA commercialization strategy that offers a path to higher and recurring revenues as customers validate linear DNA as a viable alternative to plasmid DNA. We expect some customers will license our intellectual property to enable the optimal performance of their therapeutic,” said Dr. James Hayward, president and CEO of Applied DNA. “I am especially proud of our team during this coronavirus outbreak who continue to prioritize our work on COVID-19-related therapies and diagnostics, as well as deliver linear DNA to customers without interruption. In the coming weeks and months, we expect to continue our work with all therapeutic customers to optimize LinearDNA for their unique therapeutic applications.”

LinearDNA™ is Applied DNA’s branded platform for large-scale DNA manufacture by PCR.